Targeting the Oncoprotein Smoothened by Small Molecules: Focus on Novel Acylguanidine Derivatives as Potent Smoothened Inhibitors
出版年份 2018 全文链接
标题
Targeting the Oncoprotein Smoothened by Small Molecules: Focus on Novel Acylguanidine Derivatives as Potent Smoothened Inhibitors
作者
关键词
-
出版物
Cells
Volume 7, Issue 12, Pages 272
出版商
MDPI AG
发表日期
2018-12-15
DOI
10.3390/cells7120272
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Novel-smoothened inhibitors for therapeutic targeting of naïve and drug-resistant hedgehog pathway-driven cancers
- (2018) Qing-rou Li et al. ACTA PHARMACOLOGICA SINICA
- Structural Basis of Smoothened Activation in Hedgehog Signaling
- (2018) Pengxiang Huang et al. CELL
- Phase I Study of LY2940680, a Smo Antagonist, in Patients with Advanced Cancer Including Treatment-Naïve and Previously Treated Basal Cell Carcinoma
- (2018) Johanna Bendell et al. CLINICAL CANCER RESEARCH
- Phase Ib Study of Glasdegib, a Hedgehog Pathway Inhibitor, in Combination with Standard Chemotherapy in Patients with AML or High-Risk MDS
- (2018) Michael R. Savona et al. CLINICAL CANCER RESEARCH
- Regulation of Smoothened ubiquitination and cell surface expression by a Cul4-DDB1-Gβ E3 ubiquitin ligase complex
- (2018) Shuang Li et al. JOURNAL OF CELL SCIENCE
- Novel smoothened antagonists as anti-neoplastic agents for the treatment of osteosarcoma
- (2018) Giulia Bernardini et al. JOURNAL OF CELLULAR PHYSIOLOGY
- Noncanonical hedgehog pathway activation through SRF–MKL1 promotes drug resistance in basal cell carcinomas
- (2018) Ramon J Whitson et al. NATURE MEDICINE
- Targeted inhibition of Hedgehog-GLI signaling by novel acylguanidine derivatives inhibits melanoma cell growth by inducing replication stress and mitotic catastrophe
- (2018) Silvia Pietrobono et al. Cell Death & Disease
- A novel hedgehog inhibitor for the treatment of hematological malignancies
- (2018) Peng Lin et al. ANTI-CANCER DRUGS
- Hedgehog pathway inhibitors of the acylthiourea and acylguanidine class show antitumor activity on colon cancer in vitro and in vivo
- (2018) Loredana Vesci et al. EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY
- A cell identity switch allows residual BCC to survive Hedgehog pathway inhibition
- (2018) Brian Biehs et al. NATURE
- A slow-cycling LGR5 tumour population mediates basal cell carcinoma relapse after therapy
- (2018) Adriana Sánchez-Danés et al. NATURE
- Design, synthesis, and biological evaluation of structurally modified isoindolinone and quinazolinone derivatives as hedgehog pathway inhibitors
- (2017) Deepak Bhattarai et al. EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY
- Targeting class I histone deacetylases by the novel small molecule inhibitor 4SC-202 blocks oncogenic hedgehog-GLI signaling and overcomes smoothened inhibitor resistance
- (2017) Wolfgang Gruber et al. INTERNATIONAL JOURNAL OF CANCER
- Phase I trial of the oral smoothened inhibitor sonidegib in combination with paclitaxel in patients with advanced solid tumors
- (2017) A. Stathis et al. INVESTIGATIONAL NEW DRUGS
- Synthesis and Smo Activity of Some Novel Benzamide Derivatives
- (2017) et al. MOLECULES
- The whole-genome landscape of medulloblastoma subtypes
- (2017) Paul A. Northcott et al. NATURE
- Agonist-induced dimer dissociation as a macromolecular step in G protein-coupled receptor signaling
- (2017) Julian Petersen et al. Nature Communications
- Crystal structure of a multi-domain human smoothened receptor in complex with a super stabilizing ligand
- (2017) Xianjun Zhang et al. Nature Communications
- Selective targeting of HDAC1/2 elicits anticancer effects through Gli1 acetylation in preclinical models of SHH Medulloblastoma
- (2017) Sonia Coni et al. Scientific Reports
- Design, Synthesis and Biological Evaluation of novel Hedgehog Inhibitors for treating Pancreatic Cancer
- (2017) Vinod Kumar et al. Scientific Reports
- Small-molecule Hedgehog inhibitor attenuates the leukemia-initiation potential of acute myeloid leukemia cells
- (2016) Nobuaki Fukushima et al. CANCER SCIENCE
- Cellular Cholesterol Directly Activates Smoothened in Hedgehog Signaling
- (2016) Pengxiang Huang et al. CELL
- Design, Synthesis, and Pharmacological Evaluation of 2-(2,5-Dimethyl-5,6,7,8-tetrahydroquinolin-8-yl)-N-aryl Propanamides as Novel Smoothened (Smo) Antagonists
- (2016) Gang Liu et al. JOURNAL OF MEDICINAL CHEMISTRY
- The 12-month analysis from Basal Cell Carcinoma Outcomes with LDE225 Treatment (BOLT): A phase II, randomized, double-blind study of sonidegib in patients with advanced basal cell carcinoma
- (2016) Reinhard Dummer et al. JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY
- The effect of topical diclofenac 3% and calcitriol 3 μg/g on superficial basal cell carcinoma (sBCC) and nodular basal cell carcinoma (nBCC): A phase II, randomized controlled trial
- (2016) Tjinta Brinkhuizen et al. JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY
- A phase I trial of the Hedgehog inhibitor, sonidegib (LDE225), in combination with etoposide and cisplatin for the initial treatment of extensive stage small cell lung cancer
- (2016) M. Catherine Pietanza et al. LUNG CANCER
- Posaconazole, a Second-Generation Triazole Antifungal Drug, Inhibits the Hedgehog Signaling Pathway and Progression of Basal Cell Carcinoma
- (2016) B. Chen et al. MOLECULAR CANCER THERAPEUTICS
- Structural basis of Smoothened regulation by its extracellular domains
- (2016) Eamon F. X. Byrne et al. NATURE
- Novel Acylguanidine Derivatives Targeting Smoothened Induce Antiproliferative and Pro-Apoptotic Effects in Chronic Myeloid Leukemia Cells
- (2016) Alessandra Chiarenza et al. PLoS One
- Thin and thick primary cutaneous melanomas reveal distinct patterns of somatic copy number alterations
- (2016) Valentina Montagnani et al. Oncotarget
- DYRK1B as therapeutic target in Hedgehog/GLI-dependent cancer cells with Smoothened inhibitor resistance
- (2016) Wolfgang Gruber et al. Oncotarget
- PI(4)P Promotes Phosphorylation and Conformational Change of Smoothened through Interaction with Its C-terminal Tail
- (2016) Kai Jiang et al. PLOS BIOLOGY
- Discovery of a 6-(pyridin-3-yl)benzo[d]thiazole template for optimization of hedgehog and PI3K/AKT/mTOR dual inhibitors
- (2015) Zhaohui Yang et al. BIOORGANIC & MEDICINAL CHEMISTRY LETTERS
- Smoothened Variants Explain the Majority of Drug Resistance in Basal Cell Carcinoma
- (2015) Scott X. Atwood et al. CANCER CELL
- Genomic Analysis of Smoothened Inhibitor Resistance in Basal Cell Carcinoma
- (2015) Hayley J. Sharpe et al. CANCER CELL
- RAS/MAPK Activation Drives Resistance to Smo Inhibition, Metastasis, and Tumor Evolution in Shh Pathway-Dependent Tumors
- (2015) X. Zhao et al. CANCER RESEARCH
- An Investigator-Initiated Open-Label Trial of Sonidegib in Advanced Basal Cell Carcinoma Patients Resistant to Vismodegib
- (2015) C. Danial et al. CLINICAL CANCER RESEARCH
- Design, synthesis, and structure–activity-relationship of tetrahydrothiazolopyridine derivatives as potent smoothened antagonists
- (2015) Haikuo Ma et al. EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY
- MRT-92 inhibits Hedgehog signaling by blocking overlapping binding sites in the transmembrane domain of the Smoothened receptor
- (2015) Lucile Hoch et al. FASEB JOURNAL
- Rolling the Genetic Dice: Neutral and Deleterious Smoothened Mutations in Drug-Resistant Basal Cell Carcinoma
- (2015) Scott X. Atwood et al. JOURNAL OF INVESTIGATIVE DERMATOLOGY
- Phase II evaluation of IPI-926, an oral Hedgehog inhibitor, in patients with myelofibrosis
- (2015) Koji Sasaki et al. LEUKEMIA & LYMPHOMA
- Treatment with PF-04449913, an oral smoothened antagonist, in patients with myeloid malignancies: a phase 1 safety and pharmacokinetics study
- (2015) Giovanni Martinelli et al. Lancet Haematology
- GSK-3 as potential target for therapeutic intervention in cancer
- (2015) James A. McCubrey et al. Oncotarget
- Synthesis and biological evaluation of novel benzamide derivatives as potent smoothened antagonists
- (2014) Tian-Ming Wu et al. BIOORGANIC & MEDICINAL CHEMISTRY LETTERS
- Genome Sequencing of SHH Medulloblastoma Predicts Genotype-Related Response to Smoothened Inhibition
- (2014) Marcel Kool et al. CANCER CELL
- Quiescent Sox2+ Cells Drive Hierarchical Growth and Relapse in Sonic Hedgehog Subgroup Medulloblastoma
- (2014) Robert J. Vanner et al. CANCER CELL
- The PRKCI and SOX2 Oncogenes Are Coamplified and Cooperate to Activate Hedgehog Signaling in Lung Squamous Cell Carcinoma
- (2014) Verline Justilien et al. CANCER CELL
- A Phase I Study of PF-04449913, an Oral Hedgehog Inhibitor, in Patients with Advanced Solid Tumors
- (2014) A. J. Wagner et al. CLINICAL CANCER RESEARCH
- A Phase I, Multicenter, Open-Label, First-in-Human, Dose-Escalation Study of the Oral Smoothened Inhibitor Sonidegib (LDE225) in Patients with Advanced Solid Tumors
- (2014) J. Rodon et al. CLINICAL CANCER RESEARCH
- Gli1/DNA interaction is a druggable target for Hedgehog-dependent tumors
- (2014) P. Infante et al. EMBO JOURNAL
- Discontinued in 2013: oncology drugs
- (2014) Robert Williams EXPERT OPINION ON INVESTIGATIONAL DRUGS
- The BET Bromodomain Inhibitor I-BET151 Acts Downstream of Smoothened Protein to Abrogate the Growth of Hedgehog Protein-driven Cancers
- (2014) Jun Long et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Hedgehog pathway as a potential treatment target in human cholangiocarcinoma
- (2014) Dorothee Riedlinger et al. Journal of Hepato-Biliary-Pancreatic Sciences
- Acquired resistance to the Hedgehog pathway inhibitor vismodegib due to smoothened mutations in treatment of locally advanced basal cell carcinoma
- (2014) Tjinta Brinkhuizen et al. JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY
- Hedgehog Pathway Inhibition in Chondrosarcoma Using the Smoothened Inhibitor IPI-926 Directly Inhibits Sarcoma Cell Growth
- (2014) V. T. Campbell et al. MOLECULAR CANCER THERAPEUTICS
- Smoothened (SMO) receptor mutations dictate resistance to vismodegib in basal cell carcinoma
- (2014) Sabrina Pricl et al. Molecular Oncology
- Identification of recurrent SMO and BRAF mutations in ameloblastomas
- (2014) Robert T Sweeney et al. NATURE GENETICS
- Epigenetic targeting of Hedgehog pathway transcriptional output through BET bromodomain inhibition
- (2014) Yujie Tang et al. NATURE MEDICINE
- Repurposing the FDA-Approved Pinworm Drug Pyrvinium as a Novel Chemotherapeutic Agent for Intestinal Polyposis
- (2014) Bin Li et al. PLoS One
- Structural basis for Smoothened receptor modulation and chemoresistance to anticancer drugs
- (2014) Chong Wang et al. Nature Communications
- Lipidic cubic phase injector facilitates membrane protein serial femtosecond crystallography
- (2014) Uwe Weierstall et al. Nature Communications
- A Broadly Conserved G-Protein-Coupled Receptor Kinase Phosphorylation Mechanism Controls Drosophila Smoothened Activity
- (2014) Dominic Maier et al. PLoS Genetics
- Itraconazole and Arsenic Trioxide Inhibit Hedgehog Pathway Activation and Tumor Growth Associated with Acquired Resistance to Smoothened Antagonists
- (2013) James Kim et al. CANCER CELL
- Smoothened Inhibition Leads to Decreased Proliferation and Induces Apoptosis in Esophageal Adenocarcinoma Cells
- (2013) Ali H. Zaidi et al. CANCER INVESTIGATION
- Master Transcription Factors and Mediator Establish Super-Enhancers at Key Cell Identity Genes
- (2013) Warren A. Whyte et al. CELL
- Discovery of NVP-LEQ506, a Second-Generation Inhibitor of Smoothened
- (2013) Stefan Peukert et al. ChemMedChem
- Phase I Study of the Hedgehog Pathway Inhibitor IPI-926 in Adult Patients with Solid Tumors
- (2013) A. Jimeno et al. CLINICAL CANCER RESEARCH
- Hedgehog Pathway Modulation by Multiple Lipid Binding Sites on the Smoothened Effector of Signal Response
- (2013) Benjamin R. Myers et al. DEVELOPMENTAL CELL
- Inhibition mechanism exploration of investigational drug TAK-441 as inhibitor against Vismodegib-resistant Smoothened mutant
- (2013) Tsuyoshi Ishii et al. EUROPEAN JOURNAL OF PHARMACOLOGY
- Discontinued drugs in 2012: oncology drugs
- (2013) Robert Williams EXPERT OPINION ON INVESTIGATIONAL DRUGS
- TAK-441, a novel investigational smoothened antagonist, delays castration-resistant progression in prostate cancer by disrupting paracrine hedgehog signaling
- (2013) Naokazu Ibuki et al. INTERNATIONAL JOURNAL OF CANCER
- GLI activation by atypical protein kinase C ι/λ regulates the growth of basal cell carcinomas
- (2013) Scott X. Atwood et al. NATURE
- Structure of the human smoothened receptor bound to an antitumour agent
- (2013) Chong Wang et al. NATURE
- Genomic sequencing of meningiomas identifies oncogenic SMO and AKT1 mutations
- (2013) Priscilla K Brastianos et al. NATURE GENETICS
- Correction: NVP-LDE225, a Potent and Selective SMOOTHENED Antagonist Reduces Melanoma Growth In Vitro and In Vivo
- (2013) Ahmad Jalili et al. PLoS One
- The pre-clinical absorption, distribution, metabolism and excretion properties of IPI-926, an orally bioavailable antagonist of the hedgehog signal transduction pathway
- (2013) Sherri Smith et al. XENOBIOTICA
- Structural insights into the role of the Smoothened cysteine-rich domain in Hedgehog signalling
- (2013) Rajashree Rana et al. Nature Communications
- Structure and function of the Smoothened extracellular domain in vertebrate Hedgehog signaling
- (2013) Sigrid Nachtergaele et al. eLife
- NVP-LDE-225 (Erismodegib) inhibits epithelial–mesenchymal transition and human prostate cancer stem cell growth in NOD/SCID IL2Rγ null mice by regulating Bmi-1 and microRNA-128
- (2013) R Nanta et al. Oncogenesis
- Selective Identification of Hedgehog Pathway Antagonists By Direct Analysis of Smoothened Ciliary Translocation
- (2012) Yu Wang et al. ACS Chemical Biology
- Discovery of the investigational drug TAK-441, a pyrrolo[3,2-c]pyridine derivative, as a highly potent and orally active hedgehog signaling inhibitor: Modification of the core skeleton for improved solubility
- (2012) Tomohiro Ohashi et al. BIOORGANIC & MEDICINAL CHEMISTRY
- Identification of a novel Smoothened antagonist that potently suppresses Hedgehog signaling
- (2012) Jiangbo Wang et al. BIOORGANIC & MEDICINAL CHEMISTRY
- Design, synthesis, and structure–activity-relationship of phenyl imidazoles as potent Smoothened antagonists
- (2012) Dai Cheng et al. BIOORGANIC & MEDICINAL CHEMISTRY LETTERS
- The Crosstalk of mTOR/S6K1 and Hedgehog Pathways
- (2012) Yan Wang et al. CANCER CELL
- Abstract 2819: Identification and characterization of a novel smoothened antagonist for the treatment of cancer with deregulated hedgehog signaling
- (2012) Mark H. Bender et al. CANCER RESEARCH
- Glucocorticoid Compounds Modify Smoothened Localization and Hedgehog Pathway Activity
- (2012) Yu Wang et al. CHEMISTRY & BIOLOGY
- The extracellular loops of Smoothened play a regulatory role in control of Hedgehog pathway activation
- (2012) C. E. Carroll et al. DEVELOPMENT
- Acylthiourea, Acylurea, and Acylguanidine Derivatives with Potent Hedgehog Inhibiting Activity
- (2012) Antonio Solinas et al. JOURNAL OF MEDICINAL CHEMISTRY
- Abstract B192: Preclinical characterization of BMS-833923 (XL139), a hedgehog (HH) pathway inhibitor in early clinical development
- (2012) S. B. Gendreau et al. MOLECULAR CANCER THERAPEUTICS
- Crystal structure of the µ-opioid receptor bound to a morphinan antagonist
- (2012) Aashish Manglik et al. NATURE
- Dissecting the genomic complexity underlying medulloblastoma
- (2012) David T. W. Jones et al. NATURE
- Oxysterols are allosteric activators of the oncoprotein Smoothened
- (2012) Sigrid Nachtergaele et al. Nature Chemical Biology
- Inhibiting the Hedgehog Pathway in Patients with the Basal-Cell Nevus Syndrome
- (2012) Jean Y. Tang et al. NEW ENGLAND JOURNAL OF MEDICINE
- Efficacy and Safety of Vismodegib in Advanced Basal-Cell Carcinoma
- (2012) Aleksandar Sekulic et al. NEW ENGLAND JOURNAL OF MEDICINE
- WIP1 phosphatase modulates the Hedgehog signaling by enhancing GLI1 function
- (2012) S Pandolfi et al. ONCOGENE
- Hedgehog pathway inhibitor saridegib (IPI-926) increases lifespan in a mouse medulloblastoma model
- (2012) M. J. Lee et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Small molecule inhibitors of Smoothened ciliary localization and ciliogenesis
- (2012) V. M. Wu et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Macrocyclic Hedgehog Pathway Inhibitors: Optimization of Cellular Activity and Mode of Action Studies
- (2012) Chris Dockendorff et al. ACS Medicinal Chemistry Letters
- Synthesis and biological evaluation of desmethylveramiline, a micromolar Hedgehog inhibitor
- (2011) Guillaume Guerlet et al. BIOORGANIC & MEDICINAL CHEMISTRY LETTERS
- Identification of a series of 4-[3-(quinolin-2-yl)-1,2,4-oxadiazol-5-yl]piperazinyl ureas as potent smoothened antagonist hedgehog pathway inhibitors
- (2011) Jesus M. Ontoria et al. BIOORGANIC & MEDICINAL CHEMISTRY LETTERS
- N-(2-alkylaminoethyl)-4-(1,2,4-oxadiazol-5-yl)piperazine-1-carboxamides as highly potent smoothened antagonists
- (2011) Ester Muraglia et al. BIOORGANIC & MEDICINAL CHEMISTRY LETTERS
- Vitamin D3 Inhibits Hedgehog Signaling and Proliferation in Murine Basal Cell Carcinomas
- (2011) J. Y. Tang et al. Cancer Prevention Research
- Small Molecule Antagonists in Distinct Binding Modes Inhibit Drug-Resistant Mutant of Smoothened
- (2011) Haiyan Tao et al. CHEMISTRY & BIOLOGY
- Phase I Trial of Hedgehog Pathway Inhibitor Vismodegib (GDC-0449) in Patients with Refractory, Locally Advanced or Metastatic Solid Tumors
- (2011) P. M. LoRusso et al. CLINICAL CANCER RESEARCH
- In vitro and in vivo characterization of a novel hedgehog signaling antagonist in human glioblastoma cell lines
- (2011) Pietro Ferruzzi et al. INTERNATIONAL JOURNAL OF CANCER
- Effective Targeting of Hedgehog Signaling in a Medulloblastoma Model with PF-5274857, a Potent and Selective Smoothened Antagonist That Penetrates the Blood-Brain Barrier
- (2011) A. Rohner et al. MOLECULAR CANCER THERAPEUTICS
- Discovery of PF-04449913, a Potent and Orally Bioavailable Inhibitor of Smoothened
- (2011) Michael J. Munchhof et al. ACS Medicinal Chemistry Letters
- Non-consensus GLI binding sites in Hedgehog target gene regulation
- (2010) Martina Winklmayr et al. BMC MOLECULAR BIOLOGY
- Itraconazole, a Commonly Used Antifungal that Inhibits Hedgehog Pathway Activity and Cancer Growth
- (2010) James Kim et al. CANCER CELL
- Small Molecule Inhibition of GDC-0449 Refractory Smoothened Mutants and Downstream Mechanisms of Drug Resistance
- (2010) Gerrit J. P. Dijkgraaf et al. CANCER RESEARCH
- Arsenic trioxide inhibits human cancer cell growth and tumor development in mice by blocking Hedgehog/GLI pathway
- (2010) Elspeth M. Beauchamp et al. JOURNAL OF CLINICAL INVESTIGATION
- Identification and Mechanism of Action of the Acylguanidine MRT-83, a Novel Potent Smoothened Antagonist
- (2010) H. Roudaut et al. MOLECULAR PHARMACOLOGY
- Virtual Screening-Based Discovery and Mechanistic Characterization of the Acylthiourea MRT-10 Family as Smoothened Antagonists
- (2010) F. Manetti et al. MOLECULAR PHARMACOLOGY
- Histone deacetylase and Cullin3–RENKCTD11 ubiquitin ligase interplay regulates Hedgehog signalling through Gli acetylation
- (2010) Gianluca Canettieri et al. NATURE CELL BIOLOGY
- Loss of the tumor suppressor Snf5 leads to aberrant activation of the Hedgehog-Gli pathway
- (2010) Zainab Jagani et al. NATURE MEDICINE
- DYRK1B-dependent autocrine-to-paracrine shift of Hedgehog signaling by mutant RAS
- (2010) Matthias Lauth et al. NATURE STRUCTURAL & MOLECULAR BIOLOGY
- Heterozygosity for Pten Promotes Tumorigenesis in a Mouse Model of Medulloblastoma
- (2010) Robert C. Castellino et al. PLoS One
- Arsenic antagonizes the Hedgehog pathway by preventing ciliary accumulation and reducing stability of the Gli2 transcriptional effector
- (2010) J. Kim et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Interfering with Resistance to Smoothened Antagonists by Inhibition of the PI3K Pathway in Medulloblastoma
- (2010) S. Buonamici et al. Science Translational Medicine
- Discovery of NVP-LDE225, a Potent and Selective Smoothened Antagonist
- (2010) Shifeng Pan et al. ACS Medicinal Chemistry Letters
- GDC-0449—A potent inhibitor of the hedgehog pathway
- (2009) Kirk D. Robarge et al. BIOORGANIC & MEDICINAL CHEMISTRY LETTERS
- A GLI1-p53 inhibitory loop controls neural stem cell and tumour cell numbers
- (2009) Barbara Stecca et al. EMBO JOURNAL
- Human colon cancer epithelial cells harbour active HEDGEHOG-GLI signalling that is essential for tumour growth, recurrence, metastasis and stem cell survival and expansion
- (2009) Frédéric Varnat et al. EMBO Molecular Medicine
- GLI1 is regulated through Smoothened-independent mechanisms in neoplastic pancreatic ducts and mediates PDAC cell survival and transformation
- (2009) O. Nolan-Stevaux et al. GENES & DEVELOPMENT
- Discovery of a Potent and Orally Active Hedgehog Pathway Antagonist (IPI-926)
- (2009) Martin R. Tremblay et al. JOURNAL OF MEDICINAL CHEMISTRY
- Multiple recurrent genetic events converge on control of histone lysine methylation in medulloblastoma
- (2009) Paul A Northcott et al. NATURE GENETICS
- Treatment of Medulloblastoma with Hedgehog Pathway Inhibitor GDC-0449
- (2009) Charles M. Rudin et al. NEW ENGLAND JOURNAL OF MEDICINE
- Inhibition of the Hedgehog Pathway in Advanced Basal-Cell Carcinoma
- (2009) Daniel D. Von Hoff et al. NEW ENGLAND JOURNAL OF MEDICINE
- Small-molecule inhibitors reveal multiple strategies for Hedgehog pathway blockade
- (2009) J. M. Hyman et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Smoothened Mutation Confers Resistance to a Hedgehog Pathway Inhibitor in Medulloblastoma
- (2009) R. L. Yauch et al. SCIENCE
- Inhibition of Hedgehog Signaling Enhances Delivery of Chemotherapy in a Mouse Model of Pancreatic Cancer
- (2009) K. P. Olive et al. SCIENCE
- Gli Activity Correlates with Tumor Grade in Platelet-Derived Growth Factor-Induced Gliomas
- (2008) O. J. Becher et al. CANCER RESEARCH
- Naturally Occurring Small-Molecule Inhibitors of Hedgehog/GLI-Mediated Transcription
- (2008) Takahiro Hosoya et al. CHEMBIOCHEM
- Targeting of sonic hedgehog-GLI signaling: a potential strategy to improve therapy for mantle cell lymphoma
- (2008) Ganapati V. Hegde et al. MOLECULAR CANCER THERAPEUTICS
- An orally bioavailable small-molecule inhibitor of Hedgehog signaling inhibits tumor initiation and metastasis in pancreatic cancer
- (2008) G. Feldmann et al. MOLECULAR CANCER THERAPEUTICS
- A paracrine requirement for hedgehog signalling in cancer
- (2008) Robert L. Yauch et al. NATURE
- Hedgehog signaling overrides p53-mediated tumor suppression by activating Mdm2
- (2008) Y. Abe et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Core Signaling Pathways in Human Pancreatic Cancers Revealed by Global Genomic Analyses
- (2008) S. Jones et al. SCIENCE
- The 2.6 Angstrom Crystal Structure of a Human A2A Adenosine Receptor Bound to an Antagonist
- (2008) V.-P. Jaakola et al. SCIENCE
- A Specific Cholesterol Binding Site Is Established by the 2.8 Å Structure of the Human β2-Adrenergic Receptor
- (2008) Michael A. Hanson et al. STRUCTURE
Add your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload NowCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now